Question Bank › Scarcity of the company's own output

Scarcity of the company's own output

Scarcity of the company's own output: buyers are being told to wait, and management is choosing who gets served

Calls Tested
498
Answered YES
17
Hit Rate
3.4%
rare by design

OPKO Health, Inc. (OPK) — this company's answers

NO on the Q1 2022 call 2022-05-09 D
The model's full reasoning — Q1 2022 call → NO1. The user asks to determine if, based solely on the supplied earnings call transcript, management conveys that the company currently cannot supply everything its customers want, with demand running ahead of supply, leading to waiting, allocation, rationing, or being turned away, and management actively deciding how limited supply gets distributed. 2. I need to scan the transcript for any such statements. The transcript covers OPKO Health's Q1 2022 earnings call, discussing ModeX acquisition, BioReference Laboratories (diagnostics), and the pharma segment (RAYALDEE, Somatrogon). 3. Let's look for keywords: "backlog", "wait", "allocation", "ration", "shortage", "supply", "demand", "capacity", "lead time", "sold out", "fully booked", "turn away", "prioritize", "sequencing". 4. Reviewing the text: - Phil Frost discusses ModeX acquisition, Pfizer launches, Sema4/GeneDx. - Elias Zerhouni discusses ModeX pipeline, R&D priorities. - Jon Cohen discusses BioReference: COVID testing waning, core business growth, Scarlet Health, Teladoc partnership, etc. He mentions "COVID volume trended down", "point-of-care testing remains strong", "we have added several new schools and several additional ships". No mention of inability to supply, waiting lists, or allocation. - Adam Logal discusses financials, guidance, cost reductions, milestones. - Q&A: Kevin Strang asks about R&D spend and ModeX pipeline. Jeff Cohen asks about ModeX closing, milestones, COVID testing mix, and guidance ranges. - No mention of supply constraints, backlogs, waiting times, or allocation of the company's own products/services to customers. The discussion is about demand trends (COVID testing declining, core business growing), cost cutting, and R&D pipeline. - The only "shortage" or "constraint" mentioned is not about the company's own output but about the company's own internal cost structure (labor costs) and the need to rightsize workforce. There is no mention of customers waiting for tests, or the company rationing tests. - The company is actually reducing its COVID testing expectations and focusing on core business. There is no indication of demand exceeding supply. 5. Conclusion: The transcript does not contain any statement from management conveying that the company cannot supply everything its customers want, or that buyers are experiencing waiting, allocation, or rationing.

← Back to the full OPK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company currently CANNOT SUPPLY EVERYTHING ITS CUSTOMERS WANT FROM IT — that real demand for what the company sells is running ahead of the company's ability to produce, deliver, install, or serve it — AND that, as a result, buyers are experiencing some form of waiting, allocation, rationing, or being turned away, while management is actively deciding how the limited supply gets distributed? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation as a present-tense reality: the company's own product, service, capacity, slots, units, people, or availability is the scarce thing in its market right now, and customers are feeling that scarcity directly. Any genuine expression of this counts — for example: management describing lead times, wait times, backlogs, or queues that have stretched because orders exceed what the company can currently make or do; output, inventory, or availability described as sold out, fully booked, spoken for, or allocated; customers being told they must wait, accept later delivery, take partial fulfillment, or come back later; the company choosing which customers, orders, regions, or channels get served first or get served at all; buyers competing with each other for the company's limited supply; or management explaining that it is managing demand — sequencing, prioritizing, pricing, or selecting — because it cannot currently satisfy all of it. What matters is the direction of pressure: demand pressing against the company's own ability to supply, with buyers on the outside of that constraint feeling it now, and management working the allocation rather than working to find demand. Answer NO if the company's limiting factor is described as winning demand, competition, pricing, macro softness, or customer hesitation. NO if the shortage described is of things the company BUYS — components, materials, freight, labor for hire — that constrain its shipments, without any sense that buyers are competing for the company's own scarce output. NO if the tightness is presented as a brief logistical hiccup, normal seasonality, or a one-time disruption already resolved, with no current waiting or allocation. NO if management merely reports strong demand, a good quarter, or a healthy pipeline in the usual way, with no indication that supply is failing to meet it. NO if the scarcity is only anticipated for the future rather than being experienced now. NO if the idea appears only in an analyst's question that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F

How the model reasoned

FSS · Q1 2018 → YESThe question is: Does management convey that the company currently CANNOT SUPPLY EVERYTHING ITS CUSTOMERS WANT FROM IT — demand running ahead of ability to produce, deliver, etc., buyers experiencing ...YES The transcript shows management describing current extended lead times for key products (sewer cleaners, hydro-excavators), chassis availability constraints causing customers to accelerate orders, and the company actively managing supply by adding shifts, hiring, investing in machinery, and reallocating production to reduce lead times and secure chassis—indicating demand is pressing against current capacity, with buyers feeling the wait and the company prioritizing fulfillment. This meets the criteria of present-tense scarcity and active allocation management. No, the answer is not NO, as the situation is not merely anticipated or resolved. The response is YES. The transcript shows management describing current extended lead times for key products (sewer cleaners, hydro-excavators), chassis availability constraints causing customers to accelerate orders, and the company actively managing supply by adding shifts, hiring, investing in machinery, and reallocating production to reduce lead times and secure chassis—indicating demand is pressing against current capacity, with buyers feeling the wait and the company prioritizing fulfillment. This meets the criteria of present-tense scarcity and active allocation management.
BRBR · Q4 2023 → YESThe question is: Does management convey that the company currently CANNOT SUPPLY EVERYTHING ITS CUSTOMERS WANT FROM IT — demand running ahead of production/delivery, buyers experiencing waiting/alloca...YES The transcript shows management describing ongoing tight demand-supply dynamics, limited supply preventing full restart of promotions/marketing, and active management of allocation (e.g., prioritizing production scale-up timing, weeks of supply targets, and sequencing promotions before marketing) because current output cannot yet satisfy all customer demand. This reflects buyers feeling the constraint now, with management deciding distribution and prioritization rather than simply reporting unconstrained growth. The past capacity issues are referenced as context, but the present-tense statements on remaining tightness and deliberate holding back confirm the current reality. No other factors (like external shortages) override this. Thus, the answer is YES.
HY · Q3 2021 → YESThe question is: Does management convey that the company currently CANNOT SUPPLY EVERYTHING ITS CUSTOMERS WANT FROM IT — demand running ahead of ability to produce/deliver — AND buyers experiencing wa...YES The transcript shows management describing a record backlog (98,800 units) and extended delivery lead times caused by component shortages and logistics constraints that limit shipments despite strong bookings and fully slotted plants. Customers are booking ahead to secure queue slots, and management is actively managing the backlog and margins rather than simply reporting unmet demand. This meets the criteria of current scarcity in the company's own production capacity/slots, with buyers experiencing waiting and competition for limited output. The root cause (components) is acknowledged, but the effect is that the company's output is the scarce resource now, and management is deciding allocation. Therefore, the answer is YES.

More from the question bank

Bet-the-company financing already spent on hInsulated through the downturnThe leak is fixed: the company is keeping whNobody is coming: management describes a marSecond engine igniting off the firstThe bridge is already builtAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.